Perturbation of rat hepatic metabolising enzymes by folic acid supplementation

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 637, Issue 1-2, 2008, Pages 16-22

  Canistro, D ^a   Pozzetti, L ^a   Sapone, A ^a   Broccoli, M ^a   Bonamassa, B ^a   Longo, V ^b   Lubrano, V ^b   Barillari, J ^c   Biagi, G L ^a   Paolini, M ^a  

^a Biochemical Toxicology Unit   (Italy)

^b INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^c ISTITUTO NAZIONALE DELLA NUTRIZIONE   (Italy)

Author keywords

Chemoprevention; Cytochrome P450; Folic acid; Fortification; Glutathione S transferase

Indexed keywords

CYTOCHROME P450 2C11; ETHOXYRESORUFIN; FOLIC ACID; GLUTATHIONE TRANSFERASE; TESTOSTERONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER PREVENTION; CANCER RISK; CONTROLLED STUDY; DIET SUPPLEMENTATION; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME METABOLISM; ENZYME SPECIFICITY; ENZYME SUBSTRATE; FEMALE; LIVER METABOLISM; NEURAL TUBE DEFECT; NONHUMAN; OXIDATION KINETICS; PRIORITY JOURNAL; RAT; RISK REDUCTION; STEREOCHEMISTRY; VASCULAR DISEASE; XENOBIOTIC METABOLISM;

ANIMALS; ARYL HYDROCARBON HYDROXYLASES; CYTOCHROME P-450 ENZYME SYSTEM; DIETARY SUPPLEMENTS; FEMALE; FOLIC ACID; GLUTATHIONE TRANSFERASE; LIVER; MICROSOMES, LIVER; RATS; RATS, SPRAGUE-DAWLEY; STEROID HYDROXYLASES; XENOBIOTICS;

RATTUS; RODENTIA;

EID: 37148999078     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2007.06.007     Document Type: Article

References (35)

1. Czeizel A.E., and Dudas I. Prevention of the first occurrence of neural tube defects by periconceptional vitamin supplementation. N. Engl. J. Med. 327 (1992) 1832-1835
2. Oakley G.P., and Johnston R.B. Balancing benefits and harms in public health prevention programmes mandated by governments. BMJ 329 (2004) 41-43
3. Rim E.B., Willet W.C., Hu F.B., Sampson L., Colditz G.A., Manson J.E., Hennekens C., and Stampfer M.J. Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women. JAMA 279 (1998) 359-364
4. Werler M.W., Shapiro S., and Mitchell A.A. Periconceptional folic acid exposure and risk of occurrent neural tube defects. JAMA 269 (1993) 1257-1261
5. Bollheimer L.C., Buettner R., Kullmann A., and Kullmann F. Folate and its preventive potential in colorectal carcinogenesis. How strong is the biological and epidemiological evidence?. Crit. Rev. Oncol. Hematol. 55 (2005) 13-36
6. Kim Y.I. Folate and carcinogenesis: evidence, mechanisms, and implications. J. Nutr. Biochem. 10 (1999) 66-88
7. Choi S.W., and Mason J.B. Folate and carcinogenesis: an integrated scheme. J. Nutr. 130 (2000) 129-132
8. Kim Y.I. Role of folate in colon cancer development and progression. J. Nutr. 133 (2003) 3731S-3739S
9. Cravo M.L., Mason J.B., Dayal Y., Hutchinson M., Smith D., Selhub J., and Rosenberg I.H. Folate deficiency enhances the development of colonic neoplasia in dimethylhydrazine-treated rats. Cancer Res. 52 (1992) 5002-5006
10. Kim Y.I., Salomon R.N., Graeme-Cook F., Choi S.W., Smith D.E., Dallal G.E., and Mason J.B. Dietary folate protects against the development of macroscopic colonic neoplasia in a dose responsive manner in rats. Gut 39 (1996) 732-740
11. Baggot J.E., Vaughn W.H., Juliana M.M., Eto I., Krumdieck C.L., and Grubbs C.J. Effects of folate deficiency and supplementation on methylnitrosourea-induced rat mammary tumors. J. Natl. Cancer. Inst. 84 1992 (1992) 1740-1744
12. Wargovich M.J., Chen C.D., Jimenez A., Steele V.E., Velasco M., Stephens L.C., Price R., Gray K., and Kelloff G.J. Aberrant crypts as a biomarker for colon cancer: evaluation of potential chemopreventive agents in the rat, Cancer Epidemiol. Biomarkers Prev. 5 1996 (1996) 355-360
13. Larsson S.C., Giovannucci E., and Wolk A. Folate and risk of breast cancer: a meta-analysis. J. Natl. Cancer Inst. 99 (2007) 64-76
14. Lewis S.J., Harbord R.M., Harris R., and Davey Smith G. Meta-analyses of observational and genetic association studies of folate intakes or levels and breast cancer risk. J. Natl. Cancer Inst. 98 (2006) 1607-1622
15. Talalay P. Chemoprotection against cancer by induction of phase 2 enzymes. Biofactors 12 (2000) 5-11
16. Paolini M., Pozzetti L., Piazza F., Cantelli-Forti G., and Roda A. Bile acid structure and selective modulation of murine hepatic cytochrome P450-linked enzymes. Hepatology 30 (1999) 730-739
17. Bauer C., Corsi C., and Paolini M. Stability of microsomal monooxygenases in murine liver S9 fractions derived from phenobarbital and β-naphthoflavone induced animals under various long-term conditions of storage. Teratogen. Carcin. Mut. 14 (1994) 13-22
18. Perocco P., Bronzetti G., Canistro D., Valgimigli L., Sapone A., Affatato A., Pedulli G.F., Pozzetti L., Broccoli M., Iori R., Barillari J., Sblendorio V., Legator M.S., Paolini M., and Abdel-Rahman S.Z. Glucoraphanin, the bioprecursor of the widely extolled chemopreventive agent sulforaphane found in broccoli, induces phase-I xenobiotic metabolizing enzymes and increases free radical generation in rat liver. Mutat. Res. 595 (2006) 125-136
19. Lowry O.H., Rosenbrough H.J., Farr A.L., and Randall R.J. Protein measurement with Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
20. Bailey Y.L. Techniques in Protein Chemistry (1967), Elsevier, Amsterdam pp. 340-341
21. Box G.E.P., and Hunter W.G. Statistics for Experiments (1978), Wiley, New York pp. 80-82
22. Canistro D., Della Croce C., Iori R., Barillari J., Bronzetti G., Poi G., Cini M., Caltavuturo L., Perocco P., and Paolini M. Genetic and metabolic effects of gluconasturtiin, a glucosinolate derived from cruciferae. Mutat. Res. 545 (2004) 23-35
23. Castelao J.E., Yuan J.M., Gago-Dominguez M., Skipper P.L., Tannenbaum S.R., Chan K.K., Watson M.A., Bell D.A., Coetzee G.A., Ross R.K., and Yu M.C. Carotenoids/vitamin C and smoking-related bladder cancer. Int. J. Cancer 110 (2004) 417-423
24. Greenwald D., Anderson S.A., and Nelson P.R.T. Clinical trials of vitamin and mineral supplements for cancer prevention. Am. J. Clin. Nutr. 85 (2007) 314S-317S
25. Tworoger S.S., Hecht J.L., Giovannucci E., and Hankinson S.E. Intake of folate and related nutrients in relation to risk of epithelial ovarian cancer. Am. J. Epidemiol. 163 (2006) 1101-1111
26. Campbell N.R. How safe are folic acid supplements?. Arch. Intern. Med. 156 (1996) 1638-1644
27. Morse M.A., and Stoner G.D. Cancer chemoprevention: principles and prospects. Carcinogenesis 14 (1993) 1737-1746
28. van Heeswijk R.P., Khaliq Y., Gallicano K.D., Bourbeau M., Seguin I., Phillips E.J., and Cameron D.W. The pharmacokinetics of nelfinavir and M8 during pregnancy and postpartum. Clin. Pharmacol. Ther. 76 (2004) 588-597
29. Tsutsumi K., Kotegawa T., Matsuki S., Tanaka Y., Ishii Y., Kodama Y., Kuranari M., Miyakawa I., and Nakano S. The effect of pregnancy on cytochrome P4501A2, xanthine oxidase, and N-acetyltransferase activities in humans. Clin. Pharmacol. Ther. 70 (2001) 121-125
30. Ku W.W., Bigger A., Brambilla G., Glatt H., Gocke E., Guzzie P.J., Hakura A., Honma M., Martus H.J., Obach R.S., and Roberts S. Strategy Expert Group, IWGT, Strategy for genotoxicity testing-metabolic considerations. Mutat. Res. 627 (2007) 59-77
31. Paolini M., Cantelli-Forti G., Perocco P., Pedulli G.F., Abdel-Rahman S.Z., and Legator M.S. Co-carcinogenic effect of beta-carotene. Nature 398 (1999) 760-761
32. Paolini M., Abdel-Rahman S.Z., Cantelli-Forti G., and Legator M.S. Chemoprevention or antichemoprevention? A salutary warning from the beta-carotene experience. J. Natl. Cancer Inst. 93 (2001) 1110-1111
33. Paolini M., and Nestle M. Pitfalls of enzyme-based molecular anticancer dietary manipulations: food for thought. Rev. Mutat. Res. 7704 (2003) 1-9
34. Paolini M., Sapone A., Canistro D., Antonelli M.A., and Chieco P. Diet and risk of cancer. Lancet 361 (2003) 257-258
35. Larsson S.C., Hakansson N., Giovannucci E., and Wolk A. Folate intake and pancreatic cancer incidence: a prospective study of Swedish women and men. J. Natl. Cancer Inst. 98 (2006) 407-413